Gene: AGTPBP1
Official Full Name: ATP/GTP binding carboxypeptidase 1provided by HGNC
Gene Summary: NNA1 is a zinc carboxypeptidase that contains nuclear localization signals and an ATP/GTP-binding motif that was initially cloned from regenerating spinal cord neurons of the mouse.[supplied by OMIM, Jul 2002]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO29518 | AGTPBP1 Knockout cell line (HeLa) | Human | AGTPBP1 | 1:3~1:6 | Negative | Online Inquiry |
KO29519 | AGTPBP1 Knockout cell line (HCT 116) | Human | AGTPBP1 | 1:2~1:4 | Negative | Online Inquiry |
KO29520 | AGTPBP1 Knockout cell line (HEK293) | Human | AGTPBP1 | 1:3~1:6 | Negative | Online Inquiry |
KO29521 | AGTPBP1 Knockout cell line (A549) | Human | AGTPBP1 | 1:3~1:4 | Negative | Online Inquiry |
AGTPBP1 Gene Knockout Cell Lines are specifically engineered cellular models designed to study the function of the AGTPBP1 gene and its implications in biological processes and disease states. By utilizing CRISPR/Cas9 gene editing technology, these cell lines have been modified to disrupt the AGTPBP1 gene, allowing for the investigation of its role in cellular pathways, tissue-specific gene regulation, and potential contributions to disease pathology, particularly in cancer and metabolic disorders.
The primary mechanism of these knockout cell lines involves the targeted deletion of the AGTPBP1 gene, which is crucial for understanding its biological role. This disruption can lead to altered cellular phenotypes, enabling researchers to observe downstream effects on cell signaling, proliferation, and apoptosis. Furthermore, these models facilitate investigations into the gene's interaction with other pathways, providing deeper insights into its functional contributions in health and disease.
The scientific importance of AGTPBP1 Gene Knockout Cell Lines lies in their diverse applications in both research and clinical settings. Researchers can leverage these models to elucidate molecular mechanisms underlying specific diseases, screen for potential drug targets, and validate therapeutic interventions. As personalized medicine advances, these cell lines offer powerful tools for identifying patient-specific responses to therapies involving the AGTPBP1 pathway.
One notable advantage of our AGTPBP1 Gene Knockout Cell Lines is their high specificity and reproducibility, ensuring reliable results that are pivotal in advancing scientific inquiry. Additionally, these cell lines are compatible with various assays, including high-throughput screening formats, thus enhancing experimental flexibility compared to other available models, such as siRNA knockdowns or overexpression systems.
For researchers and clinicians seeking innovative solutions to accelerate their studies and therapeutic developments, AGTPBP1 Gene Knockout Cell Lines represent a valuable resource. They enable the dissection of complex genetic interactions and provide state-of-the-art platforms to drive forward discoveries in human health.
At our company, we pride ourselves on our extensive expertise in genetic engineering and our commitment to delivering high-quality biological products. Our AGTPBP1 Gene Knockout Cell Lines are a testament to this dedication, supporting researchers in their quest for scientific advancement.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.